ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,025, issued on May 12, was assigned to DISARM THERAPEUTICS INC. (Cambridge, Mass.). "Inhibitors of SARM1" was invented by Robert Owen Hughes... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,026, issued on May 12, was assigned to DISARM THERAPEUTICS INC. (Cambridge, Mass.). "Inhibitors of SARM1" was invented by Robert Owen Hughes... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,027, issued on May 12, was assigned to ELLIPSES PHARMA LTD (London) and INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) (London). ... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,028, issued on May 12, was assigned to Vertex Pharmaceuticals Inc. (Boston). "1H-pyrazolo[4,3-Gisoquinoline and 1H-pyrazolo[4,3-gquinoline d... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,029, issued on May 12, was assigned to Galderma Holding SA (Zug, Switzerland). "JAK inhibitor compounds, method for synthesizing same and us... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,030, issued on May 12, was assigned to Principia Biopharma Inc. (Morristown, N.J.). "4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2H-imidazo[4,5-... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,031, issued on May 12, was assigned to Northwestern University (Evanston, Ill.). "Inhibitors of ubiquitin specific peptidase 22 (USP22) and ... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,032, issued on May 12, was assigned to UNIVERSITY OF HOUSTON SYSTEM (Houston) and Trustees of Tufts College (Medford, Mass.). "Pyrido[2,3-dp... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,033, issued on May 12, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "KRAS inhibitors" was invented by Brian Edward Fink (Yard... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,034, issued on May 12, was assigned to TERREMOTO BIOSCIENCES INC. (South San Francisco, Calif.). "Non-covalent modifiers of AKT1 and uses th... Read More